IQVIA Holdings Inc (NASDAQ:IQV) reported a second adjusted EPS of $2.64, up from $2.43, beating the consensus of $2.57. Provider of advanced analytics reported sales of $3.81 billion, beating the consensus of $3.79 billion. Sales increased 2.3% on a reported basis and 3.5% at constant currency compared to the second quarter of 2023. Technology & Analytics Solutions (TAS) revenue of $1.5 billion increased 2.7% on a reported basis and 3.8% at constant currency. Research & Development Solutions (R&DS) revenue reached $2.15 billion, increasing 2.4% on a reported basis and 3.3% at constant currency. Excluding the impact of pass-throughs, R&DS revenue grew 3.5% on a reported basis. Contract Sales & Medical Solutions revenue of $172 million decreased 2.3% on a reported basis and increased 2.8% at constant currency. As of June 30, 2024, R&DS contracted backlog, including reimbursed expenses, was ...